Antibody Response and Longevity Post SARS-CoV-2 Vaccine (SARS-AB)

Clinical trial NCT05515081 · COMPLETED

Trial details

NCT number: NCT05515081
Sponsor: IRCCS San Camillo, Venezia, Italy
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Vaccine Reaction

Start date: 2021-05-21
Primary completion: 2022-05-21
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.